Glucagon-like peptide-1 analogue, liraglutide, delays onset and reduces severity of experimental autoimmune encephalitis in Lewis rats

• मुख्य लेखकों: Brian DellaValle (लेखक), Gitte Brix (लेखक), Birgitte Brock (लेखक), Michael Gejl (लेखक), Anne Landau (लेखक), Arne Møller (लेखक), Jørgen Rungby (लेखक), Agnete Larsen (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2016-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

AbstractIntroduction: Recent findings indicate that metabolic disturbances are involved in multiple sclerosis (MS) pathology and influence the susceptibility to treatment, directing attention towards anti-diabetic drugs such as metformin and pioglitazone. Liraglutide, a drug of the glucagon-like pep...